drugset / Trial / NCT00527111
Pre-op Rectal ChemoRad +/- Cetuximab
Phase 2
Completed
139 enrolled
US Oncology Research
Bristol-Myers Squibb · collabEli Lilly and Company · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this research study is to find out what effects (good and bad) cetuximab has on rectal cancer.
Timeline
- Start
- 2007-02
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetuximab | Monoclonal antibody | — | — |
| Background | fluorouracil | Small molecule | — | — |